Annapurna Therapeutics is a gene therapy company focused on developing treatments for severe diseases with great unmet medical need. In May 2016 Annapurna merged with Avalanche Biotechnologies (NASDAQ:AAVL) to create Adverum Biotechnologies (NASDAQ:ADVM).